TRIEU VUONG (CEO and Chairman of the Board) purchased 0.1% of their position (80K shares) of ONCOTELIC THERAPEUTICS, INC. on the open market
Open‑market purchase worth $6.6K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/29/2022ACC: 0001493152-22-024234
DirectorOfficer10% Owner· CEO and Chairman of the Board
Since Apr 2019
+80K
Net shares
Net buyer
$6.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
80K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+80K
Price / share
$0.08
Trade value
$6.56K
% of position
0.1%
8/25/2022
90.27M→90.35M
Total
Net shares
+80K
Net value
$6.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/25/2022 | P · Purchase | +80K | $0.08 | $6.56K | 0.1% | 90.27M | 90.35M |
| Total | +80K | $6.56K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned16.78M
Common Stock
IndirectShares owned6.87M
Total
23.65M indirect23.65M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 16.78M | Indirect |
| Common Stock | 6.87M | Indirect |
| Total | 23.65M | 23.65M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported